Form 8-K - Current report:
SEC Accession No. 0000950170-24-120273
Filing Date
2024-11-04
Accepted
2024-11-04 07:00:08
Documents
11
Period of Report
2024-10-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K itos-20241031.htm   iXBRL 8-K 37128
  Complete submission text file 0000950170-24-120273.txt   150474

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT itos-20241031.xsd EX-101.SCH 24894
13 EXTRACTED XBRL INSTANCE DOCUMENT itos-20241031_htm.xml XML 4704
Mailing Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472 857-204-4583
iTeos Therapeutics, Inc. (Filer) CIK: 0001808865 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39401 | Film No.: 241420721
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)